Ayabudge LLC - 13 Jun 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: 10%+ Owner
Signature: /s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Issuer symbol: HUMA
Transactions as of: 13 Jun 2023
Net transactions value: -$12,675,000
Form type: 4
Filing time: 15 Jun 2023, 16:17:40 UTC
Previous filing: 26 May 2023
Next filing: 16 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Sale	$12,675,000	-4,875,000	-32%	$2.60	10,490,736	13 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 13, 2023, the Reporting Person sold 4,875,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.

Content

On June 13, 2023, the Reporting Person sold 4,875,000 shares of Common Stock. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.